EP
AKYA

Eversept Partners’s Akoya BioSciences AKYA Stock Holding History

Eversept Partners’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-91,568
Closed -$1.28M – 108
2021
Q3 		$1.28M Buy
+91,568
New +$1.53M 0.09% 89

Other funds holding AKYA

HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Eversept Partners's AKYA Position: Q4 2021 in Review

Eversept Partners sold out of Akoya BioSciences (AKYA) in Q4 2021, closing a stake of 91,568 shares — an estimated $1.28M sold.

Eversept Partners first reported a position in AKYA in Q3 2021 and held it in 1 quarter. The position peaked at $1.28M in Q3 2021. 45 funds tracked by Wall St. Rank hold AKYA as of Q4 2021.

  • Eversept Partners reported no remaining Akoya BioSciences position as of Q4 2021 after selling out during the quarter.
  • Eversept Partners sold 91,568 Akoya BioSciences shares in Q4 2021, an estimated $1.28M.
  • Eversept Partners first reported a position in Akoya BioSciences in Q3 2021 and held it in 1 quarter.
  • Eversept Partners's Akoya BioSciences position peaked at $1.28M in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Akoya BioSciences as of Q4 2021.

Based on Eversept Partners's 13F filing for Q4 2021, filed 14 Feb 2022.